The U.S. Food and Drug Administration (FDA) issued a warning yesterday concerning the potential risks of Fecal Microbiota for Transplantation (FMT) following the death of a patient. Two immunocompromised...

In one of the largest studies to measure the burden of antibiotic resistance in a low- or middle-income country, researchers at the Center for Disease Dynamics, Economics & Policy report that in-hospital...

A new study has found that the majority of residents in a rural village of Vietnam harbored multi-drug-resistant (MDR), colistin-resistant E. coli bacteria. Colistin is typically used as a last-resort...

Pathogenic bacteria are rapidly developing resistance to the arsenal of microbial therapies – and driving researchers to identify families of therapeutics with new modes of action. Recently, those include...

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center – Biological Defense Research Directorate (NMRC-BDRD),...

The adage that kids are growing up too fast these days has yet another locus of applicability. In a new, first-of-its-kind study, researchers from Case Western Reserve University School of Medicine have...

Achaogen, Inc., a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that its lead product candidate,...

Earlier this week, Wisconsin health officials reported on 44 cases of Elizabethkingia anophelis infections in 11 counties since Nov. 1, 2015. What is this not-so-common human pathogen, Elizabethkingia? A...